Pharmaceutical Technology, February 2023

The COVID-19 pandemic has led to many changes and shifts in the pharmaceutical industry, specifically with how pharmaceutical companies develop vaccines.

Topical eye treatments can be beneficial for patients with a growing array of eye diseases, but only if taken appropriately.

Efforts to optimize the delivery of sensitive biotherapeutics continue to evolve.

Harmonization of global regulations fosters innovation and ensures quality medicines.

A fluorescence test method was used to visually evaluate handwashing efficacy. Difficult-to-clean areas on skin such as skin folds and webbing between fingers were identified; specific washing techniques to address problem areas are proposed.

Shifting guidance and the growing prominence of computer software assurance exemplify the state of computer software validation.

The European bio/pharma industry’s high regulatory standards and GMP requirements are set to position the region as a frontrunner for pharmaceutical‑grade manufacturing of cannabis-based medicines.

A new unified initiative for patent protection in the EU to boost the competitiveness of the pharma industry is nearing completion.

Although some headway is being made into more gender-diverse executive levels in pharma, much more work is still needed.

A Congressional probe of FDA’s approval of Alzheimer’s treatment targets the agency’s interactions with drug manufacturers.

In vivo CAR-T gene therapies could resolve challenges faced by autologous and allogeneic treatments.

Susan J. Schniepp, distinguished fellow for Regulatory Compliance Associates, and Shiri Hechter, senior lab operations manager for Nelson Laboratories, provide a simple approach to validating analytical methods.

This new pioneering phase of mRNA is loaded with potential, but also obstacles and false dawns.

ROSS’ Dual Shaft Mixers can batch dispersions, suspensions, and emulsions with viscosities up to several hundred thousand centipoise.

The BioProfile FAST CDV is a fully automated viable cell density and viability analyzer.

Bio-Rad Laboratories’ EconoFit Column Packs provide resin screening for customers developing protein purification workflows.

Thermo Fisher Scientific’s QualTrak is tailored for biologics development.

The restraint to not target solely the major disease groups has provided good proportion and balance for our industry.